C83.13 Mantle cell lymphoma, intra-abdominal lymph nodes

Name of the Condition

• Mantle cell lymphoma, intra-abdominal lymph nodes
• Also known as ICD-10 code C83.13

Summary

Mantle cell lymphoma, intra-abdominal lymph nodes, is a type of non-Hodgkin lymphoma characterized by the malignant proliferation of B-cells originating from the mantle zone of lymphoid follicles. It specifically involves abnormal growth of these cells in the intra-abdominal lymph nodes. This condition is part of the broader category of non-follicular lymphomas and may present with variable clinical behavior.

Causes

The exact cause of mantle cell lymphoma, intra-abdominal lymph nodes, remains unknown. It is thought to involve genetic mutations, such as the t(11;14)(q13;q32) translocation, which leads to overexpression of cyclin D1. Specific triggers or environmental factors are not well-defined, though research suggests potential links to immune system dysregulation.

Risk Factors

• Age: More common in older adults, typically over 60 years.
• Male gender: Slightly higher incidence in males.
• Family history of lymphoma.
• Prior exposure to radiation or certain chemicals.
• Chronic infections, such as hepatitis C or HIV.
• Immunosuppressive conditions or treatments.

Symptoms

• Swollen, painless lymph nodes in the abdomen.
• Unexplained weight loss.
• Fever.
• Night sweats.
• Fatigue.
• Loss of appetite.
• Abdominal pain or fullness.

Diagnosis

Diagnosis typically involves a combination of clinical evaluation, imaging studies (e.g., CT or MRI of the abdomen), and biopsy of the affected lymph nodes. Pathological examination confirms the presence of malignant B-cells with characteristic genetic markers, such as cyclin D1 overexpression. Additional tests, including bone marrow biopsy or blood work, may be performed to assess disease extent.

Treatment Options

Treatment depends on the stage and aggressiveness of the disease. Options may include chemotherapy, immunotherapy, targeted therapy, or stem cell transplantation. Radiation therapy may be used for localized disease. Treatment plans are individualized based on patient health and disease characteristics.

Prognosis and Follow-Up

Prognosis varies based on disease stage, response to treatment, and overall health. Regular follow-up with imaging and clinical assessments is essential to monitor for recurrence or progression. Long-term management may involve ongoing surveillance and supportive care.

Complications

Potential complications include disease progression, organ involvement (e.g., spleen or gastrointestinal tract), infection due to immunosuppression, and treatment-related side effects (e.g., cytopenias or organ toxicity).

Lifestyle & Prevention

No specific preventive measures are known. Maintaining overall health, avoiding known carcinogens, and managing chronic infections may support immune function. Patients should follow recommended screening and vaccination guidelines.

When to Seek Professional Help

Seek medical attention for persistent abdominal swelling, unexplained weight loss, fever, or other systemic symptoms. Prompt evaluation is important for early diagnosis and management.

Tips for Medical Coders

Code C83.13 is specific to mantle cell lymphoma involving intra-abdominal lymph nodes. Documentation should clearly specify the anatomical site to support accurate coding. Ensure the diagnosis aligns with pathological and clinical findings, and avoid using this code for unspecified or other regional lymph node involvement.